San Francisco, 25 April 2025: The Report Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Hollow, Solid, Coated, Dissolving), By Material (Metal, Silicon, Polymer), By Application (Drug Delivery, Vaccine Delivery, Dermatology), By Region, And Segment Forecasts, 2025 - 2030
The global microneedle drug delivery systems market size is estimated to reach USD 9.46 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing demand for safer alternatives to conventional hypodermic injection and increasing awareness about minimally invasive and pain-free administration of drugs is expected to boost the market growth for microneedle drug delivery systems. Furthermore, increasing cases of diabetes are also expected to boost the market growth. For instance, as per the estimates of the World Health Organization (WHO) in 2021, approximately 463 million adults were living with diabetes, worldwide, representing 9.3% of the global population.
Microneedles offer several advantages over traditional drug delivery methods, such as oral or transdermal routes. Studies have shown that drug delivery by microneedles can improve drug absorption, bioavailability and efficacy, especially for drugs with poor water solubility or low permeability. For instance, a study published in "Journal of Controlled Release" showed that transdermal delivery of insulin using microneedles was more effective than subcutaneous injection.
The COVID-19 pandemic had a significant impact on drug delivery by microneedles. The major impact of the pandemic on the market was the increased demand for vaccine delivery. Microneedles have been explored as a potential delivery method for the COVID-19 vaccines due to their ease of use, low cost, and potential to induce a strong immune response. The pandemic has accelerated development of the microneedle-based vaccine delivery systems, with several companies and academic institutions working on COVID-19 vaccine patches.
However, the pandemic has also disrupted global supply chains, which has affected the production and distribution of microneedle-based drug delivery systems. Some manufacturers have faced challenges in obtaining raw materials and components, which has resulted in supply shortages and increased prices.
Request sample report of Microneedle Drug Delivery Systems Market@ https://www.grandviewresearch.com/industry-analysis/microneedle-drug-delivery-systems-market-report/request/rs1
According to the World Health Organization, 31% of adults worldwide, approximately 1.8 billion, failed to meet physical activity recommendations in previous years, increasing disease risk. The slowdown in healthy life expectancy improvement reflected the burden of noncommunicable diseases. In another study towards the National Diabetes Statistics Report revealed that the U.S. witnessed 34.2 million cases of diabetes in 2024, highlighting the need for innovative solutions to address these growing health concerns and improve patient outcomes.
Continuous innovation has led to the development of biodegradable and dissolvable microneedles, as well as their integration with wearable technology. Such advancements enable greater control over drug delivery kinetics and improve efficacy, making microneedle drug delivery systems (MNDDS) particularly appealing to pharmaceutical manufacturers. Moreover, the rising demand for biologics, which require efficient delivery mechanisms, has positioned microneedles as an optimal choice for therapeutic applications.
The demand for minimally invasive drug delivery methods has driven market growth further. MNDDS offer a virtually painless alternative to traditional hypodermic injections, significantly enhancing patient compliance by simplifying the drug administration process. As patients increasingly prefer self-administration options, these systems reduce the necessity for frequent hospital visits, thereby lowering overall healthcare costs.
Moreover, the COVID-19 pandemic has catalyzed interest in microneedle technology for vaccine delivery, as it allows for administration without healthcare professionals, minimizing exposure risks in clinical settings. The pandemic has ignited funding and research into microneedle solutions, instigating a long-term shift in drug delivery paradigms. Regions such as Asia Pacific and Latin America are expected to witness significant industry growth, aided by government initiatives such as the FDA’s approval of microneedle devices for clinical trials and growing investments in healthcare infrastructure.
Microneedles are the pathways to biological membranes which can create transport pathways of micron dimensions for sampling body fluids, such as for measuring the blood glucose levels in diabetic therapy.
Microneedle drug delivery system promise pain-free delivery of both small and large molecular weight active pharmaceutical ingredients into the viable epidermis avoiding contact with nerve fibers and blood vessels present in the dermal layers.
However, new developments in biotechnology, microfabrication technology, allow to demonstrate in vitro, ex vivo, and in vivo experiments, which is also paving the way for enhancement in the delivery of drugs.Read Report Overview – https://www.transparencymarketresearch.com/microneedle-drug-delivery-system-market.html High adoption in number of safety issues that are emerging, which have short and long term implications for clinicians, patients, healthcare administrators, and regulators, growing research and development initiatives, growing demand for safer alternative to conventional hypodermic injections is the most important driving factor for microneedle drug delivery system market.
According to the Centers for Disease Control and Prevention, new microneedle patch could make it easier to vaccinate people against measles and other vaccine-preventable diseases.
Around 20 million people are affected with measles every year and unfortunately, global coverage with the measles vaccine has been stagnant for the last few years at around 85% which is below the coverage percentage.
Hence, microneedle patch are designed to administer by minimally trained workers and also to simplify storage, distribution, and disposal process.
The Microneedle Drug Delivery Systems Market Research Report Forecast is a valuable source of insightful data for business strategists.
It provides the industry overview with recent trends, size, share, growth analysis, historical, futuristic data, revenue, demand and strategic development.The entire microneedle drug delivery systems market has been sub-categorized into product type and application.
The report provides an analysis of these subsets with respect to the geographical segmentation.
This research study will keep marketer informed and helps to identify the target demographics for a product or service.Request a FREE Sample Copy of Global Microneedle Drug Delivery Systems Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/microneedle-drug-delivery-systems-market/download-sampleBy Product TypeSolid Microneedle TechnologyHollow Microneedle TechnologyDissolving Microneedle TechnologyBy ApplicationDrug DeliveryVaccine DeliveryOtherThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the microneedle drug delivery systems market include 3M Company, Becton-Dickinson BD Technologies, Nanopass Technologies Ltd., Corium Inc., Microdermics, TheraJect Inc., Johnson & Johnson, Lohmann Therapie-Systeme AG, Novartis, Bayer.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for microneedle drug delivery systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
